Inflexin attenuates proinflammatory responses and nuclear factor-ΚB activation in LPS-treated microglia

European Journal of Pharmacology

Volumn 633, Issue 1-3, 2010, Pages 98-106

  Ko, Hyun Myung ^a   Koppula, Sushruta ^a   Kim, Byung Wook ^a   Kim, In Su ^a   Hwang, Bang Yeon ^b   Suk, Kyoungho ^c   Park, Eun Jung ^d   Choi, Dong Kug ^a  

^a Konkuk University   (South Korea)

^b Chungbuk National University   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

^d National Cancer Center   (South Korea)

Author keywords

BV2 cell; COX 2; Inflexin; INOS; LPS; Microglia; NF B

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; HERBACEOUS AGENT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLEXIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; INFLAMMATION; ISODON; ISODON EXCISUS; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL SURVIVAL; DITERPENES, KAURANE; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 77950027876     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.02.011     Document Type: Article

References (56)

1. Adams V., Nehrhoff B., Späte U., Linke A., Schulze P.C., Baur A., Gielen S., Hambrecht R., Schuler G. Induction of iNOS expression in skeletal muscle by IL-1β and NF-ΚB activation: an in vitro and in vivo study. Cardiovasc. Res. 2002, 54:95-104.
2. Albazzaz M.K., Pal C., Berman P., Shale D.J. Inflammatory markers of lower respiratory tract infection in elderly people. Age Ageing 1994, 23:299-302.
3. Araki E., Forster C., Dubinsky J.M., Ross M.E., Iadecola C. Cyclooxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity. Stroke 2001, 32:2370-2375.
4. Ardeshna K.M., Pizzey A.R., Devereux S., Khwaja A. The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 2000, 96:1039-1046.
5. Arimoto T., Bing G. Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration. Neurobiol. Dis. 2003, 12:35-45.
6. Bauer M.K., Lieb K., Schulze-Osthoff K., Berger M., Gebicke-Haerter P.J., Bauer J., Fiebich B.L. Expression and regulation of cyclooxygenase-2 in rat microglia. Eur. J. Biochem. 1997, 243:726-731.
7. Bhat N.R., Zhang P., Lee J.C., Hogan E.L. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 1998, 18:1633-1641.
8. Bocchini V., Mazzolla R., Barluzzi R., Blasi E., Sick P., Kettenmann H. An immortalized cell line expresses properties of activated microglial cells. J. Neurosci. Res. 1992, 31:616-621.
9. Boje K.M., Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 1992, 587:250-256.
10. Boulet I., Ralph S., Stanley E., Lock P., Dunn A.R., Green S.P. Lipopolysaccharide- and interferon-gamma-induced expression of hck and lyn tyrosine kinases in murine bone marrow-derived macrophages. Oncogene 1992, 7:703-710.
11. Carmody R.J., Chen Y.H. Nuclear factor-kappa B: activation and regulation during toll-like receptor signaling. Cell. Mol. Immunol. 2007, 4:31-41.
12. Chen C.C., Wang J.K., Chen W.C., Lin S.B. Protein kinase C beta mediates lipopolysaccharide-induced nitric-oxide synthase expression in primary astrocytes. J. Biol. Chem. 1998, 273:19424-19430.
13. Choi D.K., Pennathur S., Perier C. Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice. J. Neurosci. 2005, 28:6594-6600.
14. Chong Z.Z., Li F., Maiese K. Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res. Brain Res. Rev. 2005, 49:1-21.
15. Christman J.W., Blackwell T.S., Juurlink B.H. Redox regulation of nuclear factor kappa B: therapeutic potential for attenuating inflammatory responses. Brain Pathol. 2000, 10:153-162.
16. Da S.J., Pierrat B., Mary J.L., Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J. Biol. Chem. 1997, 272:28373-28380.
17. DeFranco A.L., Hambleton J., McMahon M., Weinstein S.L. Examination of the role of MAP kinase in the response of macrophages to lipopolysaccharide. Prog. Clin. Biol. Res. 1995, 392:407-420.
18. Fiebich B.L., Lieb K., Engels S., Heinrich M. Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells. J. Neuroimmunol. 2002, 132:18-24.
19. Fiebich B.L., Lieb K., Kammerer N., Hull M. Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia. J. Neurochem. 2003, 86:173-178.
20. Gao H.M., Jiang J., Wilson B., Zhang W., Hong J.S., Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 2002, 81:1285-1297.
21. Ghilardi J.R., Svensson C.I., Rogers S.D., Yaksh T.L., Mantyh P.W. Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia. J. Neurosci. 2004, 24:2727-2732.
22. Gonzalez-Scarano F., Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 1999, 22:219-240.
23. 15N] nitrate in biological fluids. Anal. Biochem. 1982, 126:131-138.
24. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell. Signal. 2001, 13:85-94.
25. Hong S.S., Lee S.A., Xiang H.H., Hui Z.J., Jeong H.L., Lee D.H., Lee J.J., Hong J.T., Kim Y.S., Ro J.S., Hwang B.Y. Kaurane diterpenoids from Isodon excisus inhibit LPS-induced NF-kappaB activation and NO production in macrophage RAW264.7 cells. J. Nat. Prod. 2007, 70:632-636.
26. Hunot S., Boissiere F., Faucheux B., Brugg B., Mouatt-Prigent A., Agid Y., Hirsh E.C. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 1996, 72:355-363.
27. Hunot S., Hartmann A., Hirsh E.C. The inflammatory response in the Parkinson brain. Clin. Neurosci. Res. 2001, 1:434-443.
28. Jeohn G.H., Cooper C.L., Jang K.J., Liu B., Lee D.S., Kim H.C., Hong J.S. Go{double acute}6976 Inhibitors LPS-induced microglial TNFα release by suppressing p38 MAP kinase activation. Neuroscience 2002, 114:689-697.
29. Jung B.S., Shin M.K. Encyclopedia of illustrated Korea Natural Drugs 1990, Yong Lim Sa, Seoul, pp. 845-846.
30. Koistinaho M., Koistinaho J. Role of p38 and p44/42 mitogen activated protein kinases in microglia. Glia 2002, 40:175-183.
31. Le W., Rowe D., Xie W., Ortiz I., He Y., Appel S.H. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J. Neurosci. 2001, 21:8447-8455.
32. Lee C.B. Illustrated Flora of Korea 1989, Hyang Moon Sa, Seoul, pp 661.
33. Lee S.M., Yune T.Y., Kim S.J., Kim Y.C., Oh Y.J., Markelonis G.J. Minocycline inhibits apoptotic cell death via attenuation of TNF-alpha expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co-cultures. J. Neurochem. 2004, 91:568-578.
34. Liu B., Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 2003, 304:1-7.
35. Lu D.Y., Tang C.H., Liou H.C., Teng C.M., Jeng K.C.G., Kuo S.C., Lee F.Y., Fu W.M. YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-kB in microglia. Br. J. Pharmacol. 2007, 151:396-405.
36. Madrid L.V., Wang C.Y., Guttridge D.C., Schottelius A.J., Baldwin A.S., Mayo M.W. Akt suppresses apoptosis by stimulating the transactivation potential of the Rel A/p65 subunit of NF-κB. Mol. Cell. Biol. 2000, 20:1626-1638.
37. Madrid L.V., Mayo M.W., Reuther J.Y., Baldwin A.S. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 2001, 276:18934-18940.
38. Maria B., Gerd G. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol. Ther. 2005, 107:139-154.
39. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988, 38:1285-1291.
40. McGeer P.L., Kawamata T., Walker D.G., Akiyama H., Tooyama I., McGeer E.G. Microglia in degenerative neurological disease. Glia 1993, 7:84-92.
41. Minghetti L., Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 1998, 54:99-125.
42. Minghetti L., Walsh D.T., Levi G., Perry V.H. In vivo expression of cyclooxygenase-2 in rat brain following intraparenchymal injection of bacterial endotoxin and inflammatory cytokines. J. Neuropathol. Exp. Neurol. 1999, 58:1184-1191.
43. Murphy G.M., Yang L., Cordell B. Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells. J. Biol. Chem. 1998, 273:20967-20971.
44. Nakamura Y., Si Q.S., Kataoka K. Lipopolysaccharide-induced microglial activation in culture: temporal profiles of morphological change and release of cytokines and nitric oxide. Neurosci. Res. 1999, 35:95-100.
45. Nelson P.T., Soma L.A., Lavi E. Microglia in diseases of the central nervous system. Ann. Med. 2002, 34:491-500.
46. Nomura Y. NF-kappaB activation and IkappaB alpha dynamism involved in iNOS and chemokine induction in astroglial cells. Life Sci. 2001, 68:1695-1701.
47. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B. NF-kappaB activation by tumour necrosis factor requires the Akt serinethreonine kinase. Nature 1999, 401:82-85.
48. Takada Y., Aggarwal B.B. Flavopiridol inhibits NF-κB activation induced by various carcinogens and inflammatory agents through inhibition of IκBα kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9. J. Biol. Chem. 2004, 279:4750-4759.
49. Takeda Y., Shingu T., Ichihara T., Fujita T., Yokoi T., Kida K., Ueno A. Revised structures of inflexin and related diterpenoids. Chem. Pharm. Bull. 1988, 36:4576-4580.
50. Teismann P., Vila M., Choi D.K., Tieu K., Wu D.C., Jackson-Lewis V., Przedborski S. COX-2 and neurodegeneration in Parkinson's disease. Ann. N. Y. Acad. Sci. 2003, 991:272-277.
51. Wang M.J., Lin W.W., Chen H.L., Chang Y.H., Ou H.C., Kuo J.S. Silymarin protects dopaminergic neurons against lipopolysaccharideinduced neurotoxicity by inhibiting microglia activation. Eur. J. NeuroSci. 2002, 16:2103-2112.
52. Wyss-Coray T., L.Mucke Inflammation in neurodegenerative disease - a double-edged sword. Neuron 2002, 35:419-432.
53. Xiong S., She H., Takeuchi H., Han B., Engelhardt J.F., Barton C.H., Zandi E., Giulivi C., Tsukamoto H. Signaling role of intracellular iron in NF-kappaB activation. J. Biol. Chem. 2003, 278:17646-17654.
54. Xu X., Malave A. P38 MAPK, but not p42/p44 MAPK mediated inducible nitric oxide synthase expression in C6 glioma cells. Life Sci. 2000, 67:3221-3230.
55. Yook C.S. Flora of Korea Pharmacal Botany 1981, Academy Publishing Co., Seoul, pp 468.
56. Zimmermann S., Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 1999, 286:1741-1744.